Alexion Pharmaceuticals

Updated:6/2/21
Country/Territory:U.S.
Headquarters:Boston
Industry:Pharmaceuticals
CEO:Marc Dunoyer
Website:https://www.alexion.com

Ticker:
Company type:Private
Revenues ($M):$6,070
Profits ($M):$603
Market value ($M):$33,596
Number of employees:3,837

Acquired by AstraZeneca (U.K.), July 21, 2021. Market value as of March 31, 2021.

$ millions% change
Revenues ($M):$6,069.921.6%
Profits ($M):$603.4-74.9%
Assets ($M):$18,103-
Total Stockholder Equity ($M):$11,651.2-

Profit as % of Revenues:9.9%
Profits as % of Assets:3.3%
Profits as % of Stockholder Equity:5.2%

Earnings Per Share ($):2.72
EPS % Change (from prior fiscal year):-74.6%
EPS % Change (5 year annual rate):32.3%
EPS % Change (10 year annual rate):18%

Total Return to Investors (last year):44.5%
Total Return to Investors (5 year, annualized):-3.9%
Total Return to Investors (10 year, annualized):14.5%

Measure Up Rank:329
Provides Day Care Services:yes
Has a Policy on Board Diversity:yes
Has a Policy on Diversity and Opportunity:yes

Latest available annual data reported during the collection period. Source: Refinitiv (an LSEG business).

Headquarters:Cheshire, CT
Industry:Pharmaceuticals
Sector:Health Care
Fortune 500 Rank:941
Fortune 500 Profile:https://fortune.com/fortune500/alexion-pharmaceuticals-941/
Current Streak:2
Years on List:4
CEO:David L. Hallal
Website:https://www.alxn.com

Revenue past four quarters ($M):$2,267
Net Income past four quarters ($M):$589

EPS 3 Yr Annual Growth Rate:43%
Revenue 3 Yr Annual Growth Rate:40%
Total Return 3 Yr Annual Rate:22%
Beat S&P 500 3 Yr Return:Yes

EPS 3 Yr Growth Rank:53
Revenue 3 Yr Growth Rank:25
Total Return 3 Yr Rank:86

Overall Score:1.3
Sector:Health Care
Industry:Biotechnology
CEO:Ludwig Hantson
Website:https://www.alexion.com
HQ Location:Boston

Country:U.S.
Revenues ($M) (Past 12 Months):$4,499
Profits ($M) (Past 12 Months):$1,334
Market Value as of Oct. 9, 2019 ($M):$21,266
Employees:2,656

Alexion Pharmaceuticals in Fortune Rankings

View the Full List

View the Full List

View the Full List